ACTRN12621000216819尚未招募未知
A registry to prospectively describe real-world clinicopathologic presentation and treatment selection in patients with advanced HR+, HER2- breast cancer in Australia
The Walter and Eliza Hall Institute of Medical research (WEHI)0 个研究点目标入组 300 人开始时间: 2021年3月3日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 300
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •1.Patients aged 18, of any gender and ECOG performance status diagnosed with advanced HR+, HER2- breast cancer (either de novo metastatic or relapsed), after 1st January 2020
- •2.Histological or cytological confirmation of HR+, HER2- breast cancer from either primary archival tissue or from biopsy material obtained from a metastatic site
- •a) Hormone receptor positivity is defined as greater than 1% of oestrogen receptor expression and/or greater than 1% of progesterone receptor expression via immunohistochemistry (IHC) analysis
- •b) HER2 negativity by local laboratory assessment is defined as:
- •- In situ hybridisation (ISH) non-amplification (ratio of HER2 to CEP 17 < 2.0 or single probe average HER2 gene copy number < 4 signals/cell) OR
- •- IHC 0 or IHC 1+ (as per ASCO 2018 HER2 pathology classification guidelines)
排除标准
- •Patient's under 18 who have either HR-ve or HER2 +ve breast cancer
- •Patient's who have non metastatic breast cancer
研究者
相似试验
终止
不适用
A data and sample collection study for patients with diffuse large B-cell lymphomaDiffuse large B-cell lymphomaCancerISRCTN17717066Clatterbridge Cancer Centre NHS Foundation Trust
招募中
不适用
Monocenter prospective registry to evaluate real life data of survival, treatment and consequences from changes of the WHO classification of Brain Tumors and molecular characteristics with regard to reclassification or prognosis in a German hospital - GLIO-REAC71C72Malignant neoplasm of brainMalignant neoplasm of spinal cord, cranial nerves and other parts of central nervous systemDRKS00028497niversitätsklinik Innere Medizin - OnkologiePius HospitalUniversitätsmedizin Oldenburg400
已完成
不适用
The REAL Registry for Utilization of iFR in Assessing Coronary StenosesCoronary DiseaseNCT02281110Volcano Corporation500
招募中
不适用
A registry to collect characteristics and outcomes from patients with solid tumors profiled with a next-generation sequencing test (WAYFIND-R)Solid tumors (at any anatomic location, at any disease stage)ICD-O-3, ICD-10Adverse events and drug side effectsMedDRA, ATCDRKS00028931F. Hoffmann-La Roche Ltd.15,000
已完成
3 期
Better Evidence for Selecting Transplant Fluids (BEST-Fluids)Delayed graft function in deceased donor kidney recipients.Renal and Urogenital - Kidney diseaseSurgery - Other surgeryACTRN12617000358347Australasian Kidney Trials Network (University of Qld)808